Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot and Surgical Study of Larotrectinib for Treatment of Children With Newly-Diagnosed High-Grade Glioma With NTRK Fusion

NCT04655404 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT04655404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04655404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot and Surgical Study of Larotrectinib for Treatment of Children With Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
April 8, 2021
Completion date
December 1, 2036
Enrollment
15 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse intrinsic pontine glioma, high grade glioma